Federal Register Final rule/notice: FDA is withdrawing approval of 19 NADAs and one ANADA and is amending the animal drug regulations to reflect the withdrawals. These include Fumidil B, Synchro-Mate, and Tylan Sulfa-G. The applications are being withdrawn for lack of compliance with the reporting requirements in an FDA regulation. To view this final rule, click here.
